E770-0203 Screening compound: N-[(4-ethoxyphenyl)methyl]-4-[4-(1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanamide

E770-0203 Screening compound: N-[(4-ethoxyphenyl)methyl]-4-[4-(1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanamide
E770-0203 Screening compound: N-[(4-ethoxyphenyl)methyl]-4-[4-(1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound E770-0203
N-[(4-ethoxyphenyl)methyl]-4-[4-(1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

E770-0203

Molecular Formula

C26H29N3O3 (C26 H29 N3 O3)

Compound Name

N-[(4-ethoxyphenyl)methyl]-4-[4-(1H-indol-3-yl)-1,2,3,6-tetrahydropyridin-1-yl]-4-oxobutanamide

IUPAC name

N-[(4-ethoxyphenyl)methyl]-4-[4-(1H-indol-3-yl)-1236-tetrahydropyridin-1-yl]-4-oxobutanamide

SMILES

CCOc1ccc(CNC(CCC(N(CC2)CC=C2c2c[nH]c3c2cccc3)=O)=O)cc1

InChI

InChI=1S/C26H29N3O3/c1-2-32-21-9-7-19(8-10-21)17-28-25(30)11-12-26(31)29-15-13-20(14-16-29)23-18-27-24-6-4-3-5-22(23)24/h3-10,13,18,27H,2,11-12,14-17H2,1H3,(H,28,30)

InChI Key

SCDBVHGIEVQGNV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14917303

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

431.53

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.516

Distribution Coefficient, logD

3.516

Water Solubility, LogSw

-3.48

Polar Surface Area

57.554

Acid Dissociation Constant (pKa)

13.94

Base Dissociation Constant (pKb)

-2.11

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.80

E770-0203 in Drug Discovery

Included in Screening Libraries

CORONAVIRUS Library (20774 compounds)

DGK Inhibitors Library (10558 compounds)

PLpro Library (6343 compounds)

PPI Inhibitors Tripeptide Mimetics (23972 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with E770-0203 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound E770-0203?
Check Price and Availability of E770-0203, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of E770-0203 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for E770-0203
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for E770-0203
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of E770-0203 available by request